GENEVA, May 28 -- EXELIXIS, INC. (1851 Harbor Bay ParkwayAlameda, CA 94502) filed a patent application (PCT/US2024/055905) for "5T4 ANTIBODY DRUG CONJUGATES AND METHODS OF THEIR USE" on Nov 14, 2024. With publication no. WO/2025/106658, the details related to the patent application was published on May 22, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): PETERSON, Amy (c/o Exelixis, Inc.1851 Harbor Bay ParkwayAlameda, CA 94502)
Abstract:
Provided are methods of treating cancer with a 5T4 ADC optionally in combination with a PD-L1/PD-1 inhibitor, such as pembrolizumab. Cancers treated inclu...